P2.16-06 A Phase 2 Study of Ifinatamab Deruxtecan (I-DXd; DS-7300) in Patients with Previously Treated ES-SCLC
Year: 2023
Type: article
Source: Journal of Thoracic Oncology
Authors: C. Rudin, M. Johnson, N. Girard, C.L. Hann, M.-J. Ahn, M. Nishio, J. Godard, M. Arca, M. Qian, J. Singh, L. Paz-Ares
Institutions: Memorial Sloan Kettering Cancer Center, Sarah Cannon, Institut Curie, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Samsung Medical Center, Sungkyunkwan University, The Cancer Institute Hospital, Japanese Foundation For Cancer Research, Daiichi-Sankyo (Japan), Daiichi Sankyo (United States), Hospital Universitario 12 De Octubre
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4388045828